THC-free CBD oil: why and how to choose it

THC remains a narcotic in France, whatever its source. A full-spectrum oil, even one compliant with the legal limit of 0.30%, delivers micrograms of THC with every dose. Over a regular course of use, metabolites build up and can turn a saliva test positive. The Cour de cassation confirmed on 21 June 2023 that the legality of the product purchased does not exonerate a driver who tests positive for THC.

The profiles typically concerned:

• professional drivers (taxis, private-hire vehicles, delivery riders, road haulage);
• athletes in competition, THC remaining prohibited in competition under the WADA list (CBD, by contrast, has been permitted since 2018);
• employees in safety-critical or security posts subject to workplace saliva testing;
• women planning a pregnancy or breastfeeding, for whom the precautionary principle applies to traces of THC.

The market groups two distinct chemical profiles under the expression "THC-free", and they need to be told apart.

CBD isolate

This is a cannabidiol crystal purified to 99%+, diluted in a vegetable oil (MCT, hemp, olive). No other cannabinoid, no terpene, no flavonoid. The aromatic profile is neutral. It is the safest option where drug testing is concerned: a properly produced isolate contains no quantifiable THC.

Broad spectrum

This is an oil in which the full range of hemp cannabinoids is retained (CBG, CBN, CBC, terpenes, flavonoids), but from which the THC has been removed by liquid chromatography. Residual THC content generally sits below 0.01% (100 ppm, meaning less than 0.1 mg per 10 ml bottle dosed at 10% CBD). The risk of a positive test is greatly reduced, without being strictly nil in cases of chronic use.

The "entourage effect" hypothesis — the idea that the action of cannabinoids is amplified when they are consumed together — remains under scientific investigation and has not been demonstrated by controlled clinical trials. It cannot be presented as a health argument. Broad spectrum simply offers a richer chemical profile than isolate, with no medical validation of its value.

The certificate of analysis is the only document that authenticates the composition of a bottle. A serious seller publishes it online, dated to the batch you are buying. Check:

1. The laboratory: independent of the manufacturer, Cofrac- or ISO 17025-accredited.
2. The date of the analysis: recent (less than 12 months old) and matching the batch number on the bottle.
3. The cannabinoid profile: actual CBD content compared with the content declared on the label; the mention "ND" (not detected) or "< LOQ" (below the limit of quantification) for delta-9-THC.
4. The absence of prohibited cannabinoids: HHC, H4CBD, H2CBD, HHCO, THCP, THCA and 10-OH-HHC, classified as narcotics by the ANSM in June 2024.
5. Contaminants: heavy metals, pesticides and residual extraction solvents below European Pharmacopoeia thresholds.

Without a CoA, or with a CoA more than a year old and unmatched to the batch, treat the "THC-free" claim as marketing rather than something verifiable.

Two processes dominate the production of an isolate or a broad spectrum:

• Supercritical CO2 extraction: uses carbon dioxide at high pressure and controlled temperature. No residual solvent, a clean cannabinoid profile, high cost. Widely adopted by premium brands.
• Pharmaceutical ethanol extraction: less costly, effective. It requires a solvent-purge stage that must appear in the CoA (typically < 5,000 ppm under the European Pharmacopoeia).

The step that follows extraction determines "THC-free" status:

• for an isolate, crystallisation then recrystallisation until 99%+ CBD is reached;
• for a broad spectrum, molecular distillation and liquid chromatography targeting the THC.

The legal status of wellness CBD has been settled in France since the Conseil d'État ruling of 29 December 2022: free marketing of products derived from authorised varieties containing ≤ 0.30% THC. Article 23 of the 2026 Finance Bill, which provided for a CBD excise duty, was withdrawn on 21 January 2026 — no new tax is in force.

Beware of food status: since 15 May 2026, the DGAL has been applying the European Novel Food regulation strictly. Oils sold as a "food supplement" without European authorisation are being withdrawn from the market. Oils sold as "wellness products for external use" or as cosmetics remain available. On the toxicological side, the EFSA published on 9 February 2026 a provisionally safe daily dose of 0.0275 mg/kg/day, roughly 2 mg/day for 70 kg — a threshold well below the doses commonly sold in shops.

• "THC-free" = isolate (99%+ CBD) or broad spectrum (THC < 0.01%).
• Isolate is the safest option for drivers and for athletes in competition.
• Broad spectrum retains the minor cannabinoids and terpenes, with no clinical validation of any added benefit.
• Always insist on a certificate of analysis from an independent laboratory, dated to the batch.
• Rule out any product containing HHC, H4CBD, THCP, HHCO or derivatives (prohibited since June 2024).
• CBD is not a medicine. If you have any medical doubt, consult a healthcare professional.

Isolate or broad spectrum: which should I choose?

Isolate if you are exposed to drug testing (professional driver, athlete in competition, precautionary principle). Broad spectrum if you are after a richer chemical profile for personal wellness use with no testing constraint. In both cases, the CoA is what counts.

Does a "THC-free" oil guarantee a negative saliva test?

For a 99% isolate with a compliant CoA, the risk is very low, if not nil. For a broad spectrum, a residual risk exists with chronic use, since traces below 0.01% can still accumulate. No manufacturer can guarantee a negative test with 100% certainty.

Are the perceived effects weaker with "THC-free"?

No controlled study demonstrates it. Some users report feeling a difference between isolate and broad spectrum, but the entourage-effect hypothesis has yet to be investigated clinically. European health authorities have recognised no health claim for CBD, whatever the spectrum.

What dose for a THC-free oil?

No dose is officially recommended in France. Practices observed in shops range from 5 to 50 mg of CBD per dose. Start with the minimum dose stated on the label and increase gradually. Note that the EFSA safe daily dose is 0.0275 mg/kg/day, roughly 2 mg for 70 kg, well below commercial dosages.

Are THC-free oils permitted in every country?

No. Legislation varies: some countries prohibit any trace of a cannabinoid, others require a medicine marketing authorisation. Check before travelling with your product, and do not cross a border without first verifying local legislation.

To explore our selection of isolates and broad spectrums with a certificate of analysis, [see our spectres-chimie catalogue](/categorie-produit/extracts-cbd). CBD is not a medicine. If you have any medical doubt, consult a healthcare professional.

• Conseil d'État, 29 Dec. 2022, no. 444887 (flowers/leaves) — primary
• French Highway Code, art. L.235-1 — primary
• Cour de cassation, criminal division, 21 June 2023, no. 22-85.530 — primary